![]() |
![]() |
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
(51) | INT.CL. | C07D 401/04 |
(11) | Patento numeris | 3286176 |
(13) | Dokumento rūšis | T |
(96) | Europos patento paraiškos numeris | 16718016.5 |
Europos patento paraiškos padavimo data | 2016-04-13 | |
(97) | Europos patento paraiškos paskelbimo data | 2018-02-28 |
(45) | Paskelbimo apie Europos patento išdavimą data | 2020-01-15 |
(46) | Apibrėžties vertimo paskelbimo data |
(86) | Numeris | PCT/IB2016/052107 |
Data | 2016-04-13 |
(87) | Numeris | WO 2016/170451 |
Data | 2016-10-27 |
(30) | Numeris | Data | Šalis |
201562152108 P | 2015-04-24 | US |
(72) |
HANSEN, Eric Christian, US
SEADEEK, Christopher Scott, US
|
(73) |
Pfizer Inc.,
235 East 42nd Street, New York, NY 10017,
US
|
(54) | CRYSTALLINE FORMS OF 1-((2R,4R)-2-(1H-BENZO[D]IMIDAZOL-2-YL)-1-METHYLPIPERIDIN-4-YL)-3-(4-CYANOPHENYL)UREA MALEATE |
CRYSTALLINE FORMS OF 1-((2R,4R)-2-(1H-BENZO[D]IMIDAZOL-2-YL)-1-METHYLPIPERIDIN-4-YL)-3-(4-CYANOPHENYL)UREA MALEATE |